SCHEMBL18154763

SCHEMBL18154763

Cc1nc(N2CCCCC2)nc(N)c1N1CCNCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.59
USP2 O75604 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
HRH1 P35367 1/20 0.56
CASP1 P29466 1/20 0.49
CASP4 P49662 1/20 0.49
CASP5 P51878 1/20 0.49
HRH4 Q9H3N8 1/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 2/20 0.43
APAF1 O14727 1/20 0.43
MAPT P10636 1/20 0.43
UBE2N P61088 1/20 0.43
HTT P42858 2/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700853 0.79 DHFR (0.58) HRH1HRH4ALDH1A1DHFR
Water SCHEMBL11002492 0.78 DHFR (0.56) HRH1HRH4ALDH1A1DHFR
SCHEMBL778188 0.76 SMN1; SMN2 (1.00) SMN1; SMN2USP2TDP1HRH1CASP1
SCHEMBL18154762 0.76 SMN1; SMN2 (0.46) SMN1; SMN2USP2TDP1HRH1CASP1
SCHEMBL8542091 0.74 HRH1 (1.00) SMN1; SMN2USP2TDP1HRH1CASP1
SCHEMBL4476048 0.73 HRH1 (0.43) SMN1; SMN2USP2TDP1HRH1CASP1
Acetic Acid SCHEMBL10653160 0.73 DHFR (0.55) CASP1HRH4ALDH1A1HPGDHSD17B10
SCHEMBL9488077 0.73 HRH1 (0.59) SMN1; SMN2USP2TDP1HRH1CASP1
SCHEMBL8608360 0.72 ALDH1A1 (0.53) SMN1; SMN2USP2TDP1HRH1HRH4
SCHEMBL18154725 0.72 ALDH1A1 (0.45) SMN1; SMN2USP2TDP1HRH1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283482-A1 PLK4 INHIBITORS Ludwig Institute for Cancer Research Ltd (CH) 2018-02-21 EP disclosed
WO-2016166604-A1 PLK4 INHIBITORS LUDWIG INSTITUTE FOR CANCER RESEARCH LTD (CH) 2016-10-20 WO disclosed